Design of a mobility protocol allowing to assess the impact of visual pathologies in activities of daily living for subjects with advanced visual deficits

Design of a mobility protocol allowing to assess the impact of visual pathologies in activities of daily living for subjects with advanced visual deficits.

Type: Interventional

Status of the trial: Active, Not recruiting

Orphan Drug Recognition: No

Inclusion

Opening Date: 2019-10-04
Closing Date: 2020-04-01

Criteria

Inclusion: Non-syndromic retinitis pigmentosa (RP) diagnosed ETDRS visual acuity less than 2/10 (> +0.7 logMAR; <20/100 Snellen).

Exclusion: Pregnant woman ; MMSE score without visual item ≤ 20/25

Children: No

Adults: Yes

Funder Type: industry

HCP: Principal investigators

RÉFÉRET National Hospital of Ophthalmology of Quinze-Vingts, Paris, France

HCP: Other investigators

Within ERN-EYE members

Principal investigators

Other investigators

Workgroups

Retinal Rare Eye Diseases (WG1)

Design of a mobility protocol allowing to assess the impact of visual pathologies in activities of daily living for subjects with advanced visual deficits

Within ERN-EYE members

Subscribe

This ERN is supported by: